Versant Venture Capital VI, L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-06-21
4:44 pm
Sale
2021-06-1113DALIGOS THERAPEUTICS INC
ALGS
Versant Venture Capital VI, L.P.58,317
3.800%
-19,440decrease
(-25.00%)
Filing
History
2021-05-24
4:27 pm
Unchanged
2021-05-1213DOYSTER PT PHARMA INC
OYST
Versant Venture Capital VI, L.P.2,236,888
8.600%
0
(Unchanged)
Filing
History
2021-05-03
4:57 pm
Sale
2021-04-2613DALIGOS THERAPEUTICS INC
ALGS
Versant Venture Capital VI, L.P.77,757
5.100%
-19,439decrease
(-20.00%)
Filing
History
2021-04-08
4:31 pm
Purchase
2021-03-2913DLAVA THERAPEUTICS N V SHS
LVTX
Versant Venture Capital VI, L.P.3,407,157
13.400%
3,407,157increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2